Swiss Life Asset Management »

Definium Therape shares owned by Swiss Life Asset Management

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Swiss Life Asset Management from 13F filings

Historical chart of Swiss Life Asset Management investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Swiss Life Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Swiss Life Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $187k 18k 10.54

More positions owned by Swiss Life Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Verizon Communications (VZ)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
Altria (MO)
Pfizer (PFE)
Visa Com Cl A (V)

View all positions for Swiss Life Asset Management

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
Henderson Group
Deep Track Capital
Marshall Wace
Geode Capital Management
Octagon Capital Advisors
Commodore Capital
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Candriam Luxembourg S.C.A.
Balyasny Asset Management
Two Sigma Investments

View all funds holding Definium Therape